Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results

NEXT STORY
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
PREV STORY
G1 Therapeutics and Boehringer Ingelheim Announce Commercial Availability of COSELA™ (trilaciclib), the Only FDA-Approved Multilineage Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EyePoint Pharmaceuticals Announces Presentation of Data Highlighting YUTIQ™ for Posterior Segment Uveitis at the 36th Annual Scientific Meeting of the American Society of Retina Specialists

YUTIQ™ delivers positive twelve month efficacy vs sham with reduced rates of recurrence and ...

author_avatar
NASDAQ Market News

RedHill Biopharma Issues Letter to Shareholders

TEL-AVIV, Israel, Feb. 09, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

author_avatar
NASDAQ Market News

ADMA Biologics Announces Closing of $51.75 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

author_avatar
NASDAQ Market News